CD163 and the FVIII/FXII ratio identified as novel biomarkers for early sepsis recognition

CD163 and the FVIII/FXII ratio can be used as novel markers for early clinical recognition of sepsis.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-02-04
DOI
https://doi.org/10.3389/fmed.2026.1682209
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CD163 and the FVIII/FXII ratio identified as novel biomarkers for early sepsis recognition

Jingyuan Jia, NAN YAN, Bingbing Zhu, Linhe Lu et al.
Frontiers in Medicine
Sepsis Diagnosis and Treatment
article

CD163 and the FVIII/FXII ratio identified as novel biomarkers for early sepsis recognition

Jingyuan Jia, NAN YAN, Bingbing Zhu, Linhe Lu, Yanjun Diao, Chu Chen, Shan Zhou, Jiayun Liu
article en

Abstract

CD163 and the FVIII/FXII ratio can be used as novel markers for early clinical recognition of sepsis.

Frontiers in MedicineVol. 13
Shaanxi Provincial Hospital of Traditional Chinese Medicine (CN), Xijing Hospital (CN), Air Force Medical University (CN)
Good health and well-being
Openalex Percentile: Top 67%
Sepsis Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.